Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

FMRIB’s Neurodegeneration group comprises clinical and basic neuroscientists across a range of departments and disciplines with a common interest in using neuroimaging to understand normal ageing and disease processes.

The various ways in which neurodegenerative diseases can affect the brain
The various ways in which neurodegenerative diseases can affect the brain

By providing a window on the living brain, neuroimaging has a unique role alongside genetics, cellular biology and traditional post mortem neuropathology, towards our goal of furthering understanding of the causes of neurodegenerative diseases, improving diagnosis and developing treatments. A common aspiration within the group is to identify early biomarkers of disease so that pre-symptomatic individuals at high risk can be identified and ultimately given preventative therapies.